Watchlist

Watchlist
Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals: Neglected Assets In Niche Oncology
Opportunity The best opportunities for outsized gains in biotech tend to be found in companies that are left-for-dead and/or misunderstood by market participants. However, due to the market's propensity for self-reinforcing dynamics, it can be challenging for contrarian investors to catch a …
Key events next week - healthcare
Noteworthy events during the week of April 8 - 14 for healthcare investors. More news on: Avita Medical Ltd., Immunovaccine Inc., Intercept Pharmaceuticals, Healthcare stocks news, , Read more …
Key events next week - healthcare (continued #1)
Tuesday (3/20): Oppenheimer (continued). BioLineRx (NASDAQ: BLRX ); Aerie Pharmaceuticals (NASDAQ: AERI ); United Therapeutics (NASDAQ: UTHR );Addus HomeCare (NASDAQ: ADUS ); Centene (NYSE: CNC ); Quorum Health (NYSE: QHC ); Pfenex (NYSEMKT: PFNX ); SELLAS Life Sciences (NASDAQ: SLS…
3 Things In Biotech You Should Learn Today: February 28, 2018
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotec…
Your Daily Pharma Scoop: Clovis Q4 Results, Endocyte Update, Merrimack Doses First Patient In MM-121 Mid-Stage Study
Analysis of top Seeking Alpha coverage: Clovis Oncology Today we will once again look at Clovis Oncology ( CLVS ) after the company reported its Q417 results. We had covered CLVS last week in our scoop, noting that robust Rubraca (rucaparib) sales in Q4 could boost CLVS shares. Th…
Actinium Pharma down 18% after discounting rights offering
Nano cap Actinium Pharmaceuticals ( ATNM -18.4% ) slumps on almost double normal volume after discounting its subscription rights offering to $0.50 per unit (50M units). More news on: Actinium Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more …
Stocks To Watch: Digging For Gems In The Shakeout
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Are you not entertained? The broad-based selling in equities in the U.S. and across…
B. Riley likes Actinium, sees a four-bagger
B. Riley FBR is bullish on Actinium Pharmaceuticals ( ATNM -2.4% ) based on its novel antibody-radioisotope conjugate (ARC)approach to treating blood cancers (BUY/$2.75). More news on: Actinium Pharmaceuticals, Inc., Healthcare stocks news, Read more …
Stocks to watch next week
Key events are scheduled for the companies listed below next week. More news on: Hasbro, Inc., Kimberly-Clark Corporation, McDonald's Corporation, Consumer stocks news, Financial stocks news, Healthcare stocks news, Tech stocks news, Read more …
Actinium advancing mid-stage study of leukemia med Actimab-A; shares ahead 10% premarket
Nano cap Actinium Pharmaceuticals (NYSEMKT: ATNM ) is up 10% premarket on robust volume in response to its continued advancement of a Phase 2 clinical trial assessing Actimab-A in patients with acute myeloid leukemia (AML). More news on: Actinium Pharmaceuticals, Inc., Health…
Actinium Pharmaceuticals, Inc. (ATNM)